Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Infectious & Toxicology
Filter     Order     Display # 
Date Item Title
24 Mar 2006 Idenix Provides Update on Clinical Development of Valopicitabine (NM283) for the Treatment of Hepatitis C
23 Mar 2006 TopoTarget and CuraGen initiate Phase Ib/II trial with PXD101 in combination with Velcade for Multiple Myeloma
23 Mar 2006 Novelos Therapeutics Files Ind For Novel Hepatitis C Drug
22 Mar 2006 Valeant Pharmaceuticals Reports Viser1 Results For Viramidine(R)
22 Mar 2006 Coley Pharmaceutical Group Announces Top-line Data from a Clinical Study of Actilon(TM) for Hepatitis C
22 Mar 2006 Nabi Biopharmaceuticals Announces Completion of Outside Advisory Panel Assessment of Gram-Positive Program
20 Mar 2006 Isotechnika announces preliminary 48 week clinical data from the Phase III ISA247 psoriasis trial
20 Mar 2006 Schering-Plough and PTC Therapeutics Announce Collaboration for Development of PTC's Preclinical Hepatitis C Compounds
20 Mar 2006 Q-Med submits DUROLANE regulatory file to the US FDA
17 Mar 2006 AnorMED Announces AMD070 Is Active In HIV Patients
16 Mar 2006 Metabasis Comments on Positive 48 Week HBV Data From Pradefovir Mesylate Phase 2 Study Reported by Valeant Pharmaceuticals
16 Mar 2006 Nastech Presents Successful In Vitro and In Vivo Results with Its RNAi Therapeutics Program for Influenza
15 Mar 2006 FDA Grants Cerexa Fast Track Designation for PPI-0903
14 Mar 2006 Human Genome Sciences Announces Positive Interim Results Of Phase 2b Clinical Trial Of Albuferon™ In Combination With Ribavirin In Treatment-Naïve Patients With Chronic Hepatitis C
14 Mar 2006 InSite Vision Announces Second of Two Phase 3 Clinical Trials Results Meet Primary and Secondary Efficacy End Points; Preparations for AzaSite(TM) New Drug Application
14 Mar 2006 Human Genome Sciences Reports Positive Interim Results Of Phase 2 Trial Of Albuferon™ In Combination With Ribavirin In Treatment-Experienced Patients With Chronic Hepatitis C
11 Mar 2006 Genmab Announces Update On AMG 714 Program With Amgen
10 Mar 2006 Mymetics announces NIH Plan to test HIV-AIDS vaccine candidate in non-human primate mode
10 Mar 2006 Samaritan Kicks Off Follow-On HIV Study
09 Mar 2006 Merck and Paratek Pharmaceuticals Sign Collaboration Agreement for Novel Antibiotic PTK 0796 Currently in Phase 1 Testing
09 Mar 2006 The New England Journal of Medicine Reports BARACLUDE(TM) (entecavir) Demonstrated Benefits Over Lamivudine In Treating Chronically Infected Hepatitis B Patients at 48 Weeks
09 Mar 2006 U.S. FDA Grants Traditional Approval for Gilead's Once-Daily HIV Medications Truvada(R) and Viread(R); 48-Week Data from Pivotal Study 934 Added to U.S. Prescribing Information for Both Products
08 Mar 2006 GeoVax announces IND “Safe to Proceed Status” granted by the FDA with planned Human Clinical Trials scheduled in April 2006 for its HIV/AIDS Vaccine
07 Mar 2006 Cubist Pharmaceuticals Reports Positive Outcome from FDA Anti-Infective Drugs Advisory Committee; PDUFA Date for FDA Review of CUBICIN sNDA is March 24th
06 Mar 2006 Tibotec Announces FDA Acceptance for Review of NDA for TMC114
06 Mar 2006 PharmAthene and Medarex Receive Orphan Drug Designation for Valortim(TM) to Treat Anthrax Infection
04 Mar 2006 Schering-Plough Provides Update on Phase II Study of Vicriviroc
04 Mar 2006 Anacor's Novel Topical Antifungal Agent for Onychomycosis Demonstrates Good Safety Profile and Diverse Activity in Multiple Preclinical Studies
03 Mar 2006 Wyeth Pharmaceuticals' Antibiotic Tygacil Receives Positive Opinion From European Regulatory Authority
02 Mar 2006 Sangamo BioSciences Licenses MaxCyte Cell Loading Technology for ZFP Therapeutic Program for HIV/Aids
02 Mar 2006 Enzo Receives Approval To Commence HIV Clinical Trial
01 Mar 2006 Northwest Biotherapeutics Presents New Data on Monoclonal Antibody to CXCR4
01 Mar 2006 ImQuest Pharmaceuticals, Inc. Licenses Entire Series Of Anti-HIV Therapeutic Compounds From Samjin Pharmaceutical Co.
28 Feb 2006 AVANT Announces that the European Regulatory Authorities Have Approved Rotarix(R) Rotavirus Vaccine
28 Feb 2006 ViroPharma Licenses Rights to Develop Novel Therapeutic for Treatment of Clostridium Difficile-Associated Disease
27 Feb 2006 Clinical Trial Results Show that Peregrine's First-In-Class Anti-Viral Agent Tarvacin(TM) is Safe and Well-Tolerated in HCV Patients
24 Feb 2006 FDA review date for Merck's investigational shingles vaccine extended to may 25, 2006
23 Feb 2006 Replidyne and Forest Laboratories Announce FDA Acceptance for Review of New Drug Application for Oral Antibiotic Faropenem Medoxomil
22 Feb 2006 Progenics Pharmaceuticals' HIV Drug, PRO 140, Receives FDA Fast-Track Designation
22 Feb 2006 Schering-Plough Reports NOXAFIL(R) (Posaconazole) NDA Granted FDA 6-Month Priority Review for Prevention of Invasive Fungal Infections
22 Feb 2006 Enrollment of Phase III study for Intercell’s Japanese Encephalitis Vaccine completed
22 Feb 2006 Pfizer Receives FDA Approval for EraxisTM to Treat Candidemia, a Potentially Life-Threatening Bloodstream Infection
21 Feb 2006 Ebola DNA Vaccine Produces Immune Responses in All Fully Vaccinated Volunteers in Phase 1 Trial
17 Feb 2006 CSL reveals encouraging results from Australian bird flu vaccine trial
17 Feb 2006 Biota Commences Phase 1 Clinical Trial of Common Cold Drug
17 Feb 2006 Elusys’ anthrax drug, Anthim™, superior to antibiotic as a post-exposure monotherapy
17 Feb 2006 New Data on Tibotec HIV/AIDS Investigational Product Portfolio
17 Feb 2006 FDA Approves Vusion(TM) Ointment for the Treatment of Diaper Dermatitis Complicated by Candidiasis
16 Feb 2006 American Pharmaceutical Partners Receives Two FDA Approvals for Ceftriaxone for Injection, USP, Maintaining Company's Leadership Position in the Cephalosporin Market
15 Feb 2006 Biolex Therapeutics Presents Results Highlighting Benefits of Locteron(TM) at 'Breakthroughs in Hepatitis' Session
 
<< Start < Prev 21 22 23 24 25 26 Next > End >>
Results 1151 - 1200 of 1267

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics